Orthopaedic Research UK is a medical charity that supports research and innovation in bone and joint health.
Portfolio
2
companies
Renovos
Renovos creates nanoclay gel technology to transform orthopaedic surgery and regenerative medicine.
Renovos Biologics
Renovos Biologics develops targeted nanoclay carriers for regenerative medicine.
Ronald Furlong
Surgeon
The funding will support the clinical progression and regulatory advancement of the company proprietary nanoclay platform.
"advancing the development of [their] orthobiologics product, RENOVITE® nanoclay, and progressing through regulatory milestones to get this technology closer to clinic and spinal fusion patients."
Orthopaedic Research UK provided the pre-seed funding through the newly launched Ronald Furlong Fund.
"We are the first charity supporting start-ups with a focus on musculoskeletal health in the UK. The Ronald Furlong Fund initiative will play an important role in assisting entrepreneurs and innovators to quickly turn ideas into reality, with measurable benefits for the entire healthcare ecosystem. Effective collaboration with HS. was instrumental in identifying Renovos and their exciting technology, and I am delighted to welcome them as ORUK’s first investment."
